Skip header and navigation
The BC Cancer Library

Delivering timely service and evidence-informed resources to people in BC and the Yukon facing cancer and those involved in oncology care or research.

Refine by:

3 records – page 1 of 1.

NCCN guidelines for patients : immunotherapy side effects: CAR T-cell therapy

https://bccalibrary.andornot.com/en/permalink/catalog124898
National Comprehensive Cancer Network (NCCN). Plymouth Meeting, PA: National Comprehensive Cancer Network , 2022.
Audience
Patient or Public
Call Number
QZ267 N277c 2022
Availability
4 copies, 4 available
  2 read online  
Alternate Title
National Comprehensive Cancer Network guidelines for patients : immunotherapy side effects: CAR T-cell therapy
Corporate Author
National Comprehensive Cancer Network (NCCN)
Place of Publication
Plymouth Meeting, PA
Publisher
National Comprehensive Cancer Network
Publication Date
2022
Physical Description
32 p. : col. ill. ; 29 cm
Series
NCCN guidelines for patients
Subjects
Popular Work
Immunotherapy, Adoptive - adverse effects
Immunotherapy - adverse effects
ISBN
9781954190627
Language
English
Material Type
Book
Online
Audience
Patient or Public
Location
Internet
Abbotsford Cancer Info Ctr
Kelowna Cancer Info Ctr
Victoria Cancer Info Ctr
Vancouver Library
Call Number
QZ267 N277c 2022
Read Online

Copies

c.1 BC Cancer Agency ARHCC Cancer Info Ctr Available
c.1 BC Cancer Agency KEL Cancer Info Ctr Available
c.1 BC Cancer Agency VIC Cancer Info Ctr Available
c.1 BC Cancer Agency VAN Library Available
Show Less

NCCN guidelines for patients : immunotherapy side effects - immune checkpoint inhibitors

https://bccalibrary.andornot.com/en/permalink/catalog124900
National Comprehensive Cancer Network (NCCN). Plymouth Meeting, PA: National Comprehensive Cancer Network , 2022.
Audience
Patient or Public
Call Number
QZ267 N277i 2022
Availability
4 copies, 4 available
  2 read online  
Alternate Title
National Comprehensive Cancer Network guidelines for patients : immunotherapy side effects - immune checkpoint inhibitors
Corporate Author
National Comprehensive Cancer Network (NCCN)
Place of Publication
Plymouth Meeting, PA
Publisher
National Comprehensive Cancer Network
Publication Date
2022
Physical Description
58 p. : col. ill. ; 29 cm
Series
NCCN guidelines for patients
Subjects
Popular Work
Immunotherapy - adverse effects
ISBN
9781954190573
Language
English
Material Type
Book
Online
Audience
Patient or Public
Location
Internet
Abbotsford Cancer Info Ctr
Kelowna Cancer Info Ctr
Victoria Cancer Info Ctr
Vancouver Library
Call Number
QZ267 N277i 2022
Read Online

Copies

c.1 BC Cancer Agency ARHCC Cancer Info Ctr Available
c.1 BC Cancer Agency VIC Cancer Info Ctr Available
c.1 BC Cancer Agency VAN Library Available
c.1 BC Cancer Agency KEL Cancer Info Ctr Available
Show Less

Treating cancer with immunotherapy and targeted therapy

https://bccalibrary.andornot.com/en/permalink/catalog124276
Olle, David A. Dulles, VA: Mercury Learning and Information , 2022. 2nd ed.
Audience
Patient or Public
Call Number
QZ266 O49t 2022
Availability
5 copies, 5 available
  1 read online  
Author
Olle, David A.
Edition
2nd ed.
Place of Publication
Dulles, VA
Publisher
Mercury Learning and Information
Publication Date
2022
Physical Description
xiii, 161 pages : colour illustrations ; 23 cm
Series
Proquest Ebook Central
Subjects
Neoplasms - therapy
Immunotherapy
Precision Medicine
Popular Work
ISBN
9781683927549
9781683927532
Language
English
Material Type
Ebook
Book
Audience
Patient or Public
Location
Abbotsford Cancer Info Ctr
Vancouver Library
Victoria Cancer Info Ctr
Kelowna Cancer Info Ctr
Internet
Call Number
QZ266 O49t 2022
Website Notes
Patients and the public of BC and the Yukon can access this title by emailing library@bccancer.bc.ca or calling 1.888.675.8001 x 7000 (toll-free) to obtain a username and password.
Read Online

Copies

c.1 BC Cancer Agency VAN Library Available
c.1 BC Cancer Agency VIC Cancer Info Ctr Available
c.1 BC Cancer Agency KEL Cancer Info Ctr Available
c.1 BC Cancer Agency SUR Cancer Info Ctr Available
c.1 BC Cancer Agency ARHCC Cancer Info Ctr Available
Show Less